Program Director: Terry A. Day, M.D.
Address: Head & Neck Tumor Program
Hollings Cancer Center
Box 550, 135 Rutledge Avenue
Charleston, SC 29425
Phone: (843) 792-8363
Fax: (843) 792-0546
Chairman of Department: Paul R. Lambert, M.D.
Program Coordinator: Ann Durgun
The Head and Neck Tumor Center at the Medical University of South Carolina (MUSC) is one of the largest programs in the US devoted to the care of the head and neck cancer patient. The program is based within the Hollings Cancer Center at MUSC, the only NCI-designated cancer center in South Carolina. The focus of the MUSC Head and Neck Tumor Center is on providing compassionate, comprehensive and innovative care to all patients and their families. Overall, 750 – 800 new patients with head and neck cancer are evaluated at MUSC annually. The MUSC Head and Neck Tumor Center has a strong multidisciplinary focus, with providers from Head and Neck Surgery, Radiation Oncology, Medical Oncology, Maxillofacial Prosthdontics, Speech/ Swallowing Therapy, Dental Oncology, Nutrition, Social Work and related fields working together to provide the optimal care for head and neck cancer patients. In 2011, the Head and Neck Tumor Center was cited as the best interdisciplinary clinical program at MUSC. The Head and Neck Tumor Center also has an extremely robust research portfolio. Currently, the program has 25 open clinical trials in head and neck cancer, along with 10 NIH-funded basic science laboratories or translational research programs with over $4 Million annual in research funding. The MUSC Head and Neck Tumor Center is a division of the MUSC Department of Otolaryngology-Head and Neck Surgery but approved as an institutional center at MUSC crossing many disciplines. The Department of Otolaryngology – HNS at MUSC is ranked 10th nationally among Otolaryngology departments for NIH funding, with over $5.5 million in current grants. The most recent US News & World report study ranked the MUSC Department of Otolaryngology as #2 in the Southeastern US.
The Fellowship in Surgical Oncology and Microvascular Reconstruction of the Head and Neck at MUSC provides the highest level of training in the management and surgical treatment of head and neck cancer. Each Fellow enters as Clinical Instructor level faculty and performs approximately 280 major cases per year as primary surgeon. Depending on their level of interest, fellows will participate in 50 – 100 cases of microvascular free tissue transfer for head and neck reconstruction. Fellows also have the opportunity to perform surgical procedures with surgeons from other specialties, including Facial Plastics, Dermatologic Surgery, Oral and Maxillofacial Surgery, Ophthalmology, Thoracic Surgery, and Vascular Surgery. In addition to working with senior faculty in a clinical setting, each Fellow also has an independent head and neck cancer clinic and is not responsible for general otolaryngology patients. In this setting, Fellows evaluate new patients each week and have primary management responsibility for all patients seen in their clinic. All patients evaluated in the clinic who require surgical intervention are operated upon by the Fellows with the supervision or assistance of senior faculty as appropriate. In this manner, Fellows have the opportunity to function largely independently as junior faculty in accordance with their skill and experience levels. Fellows also have short clinical rotations with specialists from Radiation Oncology, Medical Oncology, Oral Pathology, Head & Neck Pathology, Maxillofacial Prosthodontics and Speech Pathology. Research opportunities abound. Fellows participate in all Head and Neck Clinical Trials meetings and are required to complete at least one translational research project during the fellowship along with other clinical studies or review projects. For those interested in undertaking more dedicated research time, there is the option to devote an additional year exclusively to research.
Goals and Objectives:
The goals and objectives of the Fellowship in Surgical Oncology and Microvascular Reconstruction of the Head and Neck are as follows:
Applicants for the head and neck oncologic and reconstructive fellowship must have completed a residency program in Otolaryngology, General Surgery or Plastic Surgery. The applicant should have significant experience in surgery of the head and neck and be BC/BE in Otolaryngology, General Surgery, or Plastic Surgery. A South Carolina medical license must be obtained prior to the fellowship year. Applicants are required to complete a written application,
including three letters of reference, and a personal on-site interview. All interested US and Canadian fellowship applicants must be registered with the Match Program of the Advanced Training Council of The American Head and Neck Society to be considered for a position. The Medical University of South Carolina is an equal opportunity affirmative action employer. Women and minorities are encouraged to apply.
The Fellow will participate in the outpatient evaluation and treatment, inpatient care, and surgical treatment of approximately 400 new patients per year. The Fellow will work under the supervision of senior faculty, but will also have the opportunity to increasingly function independently during the course of the training year as appropriate. Trainees are evaluated monthly by program faculty and semiannual reviews are performed with the Program Director in person.
The Fellow will be provided a certificate of completion of the fellowship upon satisfactory achievement of required goals and objectives by MUSC. In addition, Fellows are expected to apply for accreditation and membership in the American College of Surgeons and the Advanced Training Council of the American Head and Neck Society.
Careers of Former Fellows:
Michael Burnett, M.D. - New York Otolaryngology Group, New York, NY.
Serap Koybasi, M.D. - Abant Izzet Baysal University, Bolu, Turkey.
Joshua D. Hornig, M.D. - Medical University of South Carolina, Charleston, SC.
Allen O. Mitchell, M.D. - Naval Medical Center, Portsmouth, VA.
Oleg N. Militsakh, M.D. - University of Nebraska Medical Center, Omaha, NE.
Luke O. Buchmann, M.D. - University of Utah, Salt Lake City, UT.
Nadia Mohyuddin, M.D. - Baylor College of Medicine, Houston, TX.
Tanya Fancy, M.D. - West Virginia University Health Sciences Center, WV.
Wayne Cardoni, M.D. - National Naval Medical Center, Bethesda, MD.
Trinita Cannon, M.D. - University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Barry T. Malin, M.D., M.P.P. – Medical University of South Carolina, Charleston, SC.
Akash Anand, M.D. – Ochsner Health System/Tulane Medical Center New Orleans, LA.
Faculty Involved with the Fellowship:
Terry Day, MD Head & Neck Surgery
Joshua Hornig, MD Head & Neck Surgery/Microvascular
Eric Lentsch, MD Head & Neck Surgery
Barry T. Malin, MD, MPP Head & Neck Surgery/Microvascular
Judith Skoner, MD Head & Neck Surgery/Microvascular
Roy Sessions, MD Head & Neck Surgery
Krishna Patel, MD, PhD Facial Plastic & Reconstructive Surgery
Anand Sharma, MD Radiation Oncology
Keisuke Shirai, MD Medical Oncology
Paul O’Brien, MD Medical Oncology
Bonnie Martin Harris, PhD Speech Pathology
Betsy Davis, DMD Maxillofacial Prosthodontics
Mary Richardson DDS, MD Head & Neck Pathology
Brad Neville DDS Oral Pathology
Zoran Rumboldt, MD Head & Neck Radiology
Gisele Matheus, MD Head & Neck Radiology
Vittoria Spampinato, MD Head & Neck Radiology
Jyotika Fernandes, MD Endocrine Oncology
Alex Vandergift, MD Neurosurgery/Skull Base Surgery
Sunil Patel, MD Neurosurgery/Skull Base Surgery
Joel Cook, MD Mohs & Dermatologic Oncology
M Rita Young, PhD Head & Neck Immunology
Besim Ogretmen, PhD Lipidomics in Head and Neck Cancer
Keith Kirkwood, PhD Head & Neck Tumor Biology
Steve Rosenzweig, PhD Signaling in Head and Neck Cancer